Related Experiment Videos

Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches

Ralf G Seipelt1, Andreas Franke, Jaime F Vazquez-Jimenez

  • 1Department of Thoracic and Cardiovascular Surgery, Medical Clinic I, Aachen, Germany. rseipelt@childrensmemorial.org

Insights

Thromboembolism is common after Fontan procedures. Coumadin (warfarin) significantly reduces these risks compared to no medication, suggesting its use for Fontan patients.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiovascular Surgery

Background:

  • Patients undergoing the Fontan procedure face a high risk of thromboembolic complications.
  • Anticoagulant therapy management varies significantly among these patients.
  • This study investigates thromboembolism frequency and clinical relevance post-Fontan.

Purpose of the Study:

  • To analyze the incidence and clinical significance of thromboembolism following Fontan procedures.
  • To compare the effectiveness of different anticoagulant therapeutic approaches.

Main Methods:

  • 101 patients (mean age 7.3 years) underwent Fontan-type procedures (modified Fontan or total cavopulmonary connection) between 1986-1998.
  • Follow-up averaged 5.7 years, with echocardiography and/or angiography performed on survivors.
  • Three anticoagulant groups were compared: no medication (n=45), aspirin (n=14), and Coumadin (n=26).

Main Results:

  • Thromboembolic events occurred in 15.3% of patients (3.3 events/100 patient-years), peaking in the first year and again after 10 years.
  • Coumadin therapy showed a significant benefit in preventing thromboembolism compared to no medication (p=0.031).
  • Cumulative event rates were 4.2/100 patient-years (no medication), 1.6/100 patient-years (aspirin), and 1.1/100 patient-years (Coumadin), with no significant bleeding complications.

Conclusions:

  • Thromboembolism is a frequent complication after Fontan procedures, with distinct early and late peaks.
  • Coumadin demonstrates superior efficacy in preventing thromboembolic events post-Fontan.
  • Initial oral anticoagulation therapy with Coumadin is recommended for patients undergoing Fontan-type operations.
Abstract

Related Concept Videos